Submitted:
18 October 2024
Posted:
18 October 2024
Read the latest preprint version here
Abstract
Objectives: Sutureless aortic valve replacement (Su-AVR) is gaining popularity due to its simplified implantation technique and advantages such as shorter operative time. We evaluated the Intuity aortic bioprosthesis and investigated the mechanical adaptation of its prosthetic stent and its susceptibility to cusp fibrosis, dysfunction, flutter, and obstruction after implantation, if any. Methods: N=19 patients received a Su-AVR with the Intuity bioprosthesis at our institution between 2018 and 2020. We analysed the clinical outcomes, anatomical and stereotactical features using the OSIRIX DICOM Pixmeo software CT images, and the radial force (RF) profile using the RX Machine apparatus (Machine Solutions Inc., located in Flagstaff, AZ), for evaluating the valve’s stent according to ISO standards. Results: In all three-dimensional reconstructions, the Intuity stent showed no degree of deformation or ovalisation. Annulus ovality was 0 and 10.4%, respectively, and ovality of the skirt at its open edge was 2 and 19.9%, respectively. Intuity's RF was significantly higher than other transcatheter aortic devices, exceeding the tester's measurement range. Conclusions: The Intuity Elite bio-prosthesis demonstrates remarkable ovality, RFs, and rigidity that could relate to a potential for dynamic adjustment to the hemodynamic patterns in the aortic root postoperatively. Its high RFs at the annulus may explain the resistance to deformation, ensuring harmonious, natural-like cusp mobility. This may reduce the risk of turbulence-induced fibrosis and increased transvalvular pressure gradients, and may clinically translate into less hemolysis. To validate the clinical impact of our findings, if any, additional research with larger sample and extended follow-up is essential.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Data Source
2.2. Study Cohort
2.3. Operative Technique
2.4. The Intuity Edwards Bio-Prosthesis
2.5. Computed Tomography Analysis
2.6. In Vitro Radial Force Assessment
2.7. Transthoracic and Trans-Esophageal Echocardiography Assessments
2.8. Statistical Analysis
3. Results
3.1. Clinical Findings
3.2. Computed Tomography Analysis
3.3. Radial Force RF Measurements
4. Discussion
Limitations of the Study
5. Conclusion
Supplementary Materials
Conflicts of Interest
Abbreviations
References
- Butcher JT, Simmons CA, Warnock JN. Mechanobiology of the aortic heart valve. J Heart Valve Dis 2008, 17, 62–73. [Google Scholar]
- Rossini G, Caimi A, Redaelli A, Votta E. Subject-specific multiscale modeling of aortic valve biomechanics. Biomech Model Mechanobiol 2021, 20, 1031–1046. [Google Scholar] [CrossRef] [PubMed]
- Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 2017, 135, e146–e603. [Google Scholar]
- Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24, 1231–1243. [Google Scholar] [CrossRef] [PubMed]
- Funkat A, Beckmann A, Lewandowski J, Frie M, Ernst M, Schiller W, et al. Cardiac surgery in Germany during 2013: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2014, 62, 380–392. [Google Scholar] [CrossRef] [PubMed]
- Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation 1982, 66, 1105–1110. [Google Scholar] [CrossRef]
- Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 1981, 64 Pt 2, Ii184–8. [Google Scholar]
- Lund, O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation 1990, 82, 124–139. [Google Scholar]
- Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg, S: Suppl).
- O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009, 88, S23–42. [Google Scholar] [CrossRef]
- Bouma BJ, van der Meulen JH, van den Brink RB, Smidts A, Cheriex EC, Hamer HP, et al. Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosis. J Clin Epidemiol 2004, 57, 815–823. [Google Scholar] [CrossRef]
- Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005, 26, 2714–2720.
- Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008, 135, 180–187. [Google Scholar] [CrossRef] [PubMed]
- Di Eusanio M, Fortuna D, De Palma R, Dell'Amore A, Lamarra M, Contini GA, et al. Aortic valve replacement: results and predictors of mortality from a contemporary series of 2256 patients. J Thorac Cardiovasc Surg 2011, 141, 940–947. [Google Scholar] [CrossRef] [PubMed]
- Doenst T, Borger MA, Weisel RD, Yau TM, Maganti M, Rao V. Relation between aortic cross-clamp time and mortality--not as straightforward as expected. Eur J Cardiothorac Surg 2008, 33, 660–665. [Google Scholar] [CrossRef]
- Al-Sarraf N, Thalib L, Hughes A, Houlihan M, Tolan M, Young V, et al. Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients. Int J Surg 2011, 9, 104–109. [Google Scholar] [CrossRef]
- Schlömicher M, Haldenwang PL, Moustafine V, Bechtel M, Strauch JT. Minimal access rapid deployment aortic valve replacement: initial single-center experience and 12-month outcomes. J Thorac Cardiovasc Surg 2015, 149, 434–440. [Google Scholar] [CrossRef]
- Ferrari E, Roduit C, Salamin P, Caporali E, Demertzis S, Tozzi P, et al. Rapid-deployment aortic valve replacement versus standard bioprosthesis implantation. J Card Surg 2017, 32, 322–327. [Google Scholar] [CrossRef]
- Liakopoulos OJ, Gerfer S, Weider S, Rahmanian P, Zeriouh M, Eghbalzadeh K, et al. Direct Comparison of the Edwards Intuity Elite and Sorin Perceval S Rapid Deployment Aortic Valves. Ann Thorac Surg 2018, 105, 108–114. [Google Scholar] [CrossRef]
- Sohn SH, Jang MJ, Hwang HY, Kim KH. Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: A meta-analysis. J Thorac Cardiovasc Surg 2018, 155, 2402–2412. [Google Scholar] [CrossRef]
- Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Sutureless perceval aortic valve replacement: results of two European centers. Ann Thorac Surg 2012, 93, 1483–1488. [Google Scholar] [CrossRef]
- D'Onofrio A, Cibin G, Lorenzoni G, Tessari C, Bifulco O, Lombardi V, et al. Propensity-Weighted Comparison of Conventional Stented and Rapid-Deployment Aortic Bioprostheses. Curr Probl Cardiol 2023, 48, 101426. [Google Scholar] [CrossRef] [PubMed]
- Laufer, G. The 10 Commandments of Rapid Deployment Intuity Valve Implantation. Innovations (Phila) 2023, 18, 316–319. [Google Scholar] [CrossRef] [PubMed]
- Sadri V, Bloodworth CHt, Madukauwa-David ID, Midha PA, Raghav V, Yoganathan AP. A mechanistic investigation of the EDWARDS INTUITY Elite valve's hemodynamic performance. Gen Thorac Cardiovasc Surg 2020, 68, 9–17. [Google Scholar] [CrossRef] [PubMed]
- Barnhart GR, Accola KD, Grossi EA, Woo YJ, Mumtaz MA, Sabik JF, et al. TRANSFORM (Multicenter Experience With Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement) US clinical trial: Performance of a rapid deployment aortic valve. J Thorac Cardiovasc Surg 2017, 153, 241–251. [Google Scholar] [CrossRef] [PubMed]
- Accola KD, Chitwood WR, Jr. , Mumtaz MA, Barnhart GR. Step-by-Step Aortic Valve Replacement With a New Rapid Deployment Valve. Ann Thorac Surg 2018, 105, 966–971. [Google Scholar] [CrossRef]
- Young C, Laufer G, Kocher A, Solinas M, Alamanni F, Polvani G, et al. One-year outcomes after rapid-deployment aortic valve replacement. J Thorac Cardiovasc Surg 2018, 155, 575–585. [Google Scholar] [CrossRef]
- Egron S, Fujita B, Gullón L, Pott D, Schmitz-Rode T, Ensminger S, et al. Radial Force: An Underestimated Parameter in Oversizing Transcatheter Aortic Valve Replacement Prostheses: In Vitro Analysis with Five Commercialized Valves. ASAIO Journal 2018, 64, 536–543. [Google Scholar] [CrossRef]
- Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging 2017, 18, 254–275. [Google Scholar] [CrossRef]
- Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015, 16, 233–270. [Google Scholar] [CrossRef]
- Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009, 22, 975–1014. [Google Scholar]
- Taghiyev ZT, Bechtel M, Schlömicher M, Useini D, Taghi HN, Moustafine V, et al. Early-Term Results of Rapid-Deployment Aortic Valve Replacement versus Standard Bioprosthesis Implantation Combined with Coronary Artery Bypass Grafting. Thorac Cardiovasc Surg 2023, 71, 519–527. [Google Scholar] [CrossRef] [PubMed]
- Dokollari A, Torregrossa G, Sicouri S, Veshti A, Margaryan R, Cameli M, et al. Pearls, pitfalls, and surgical indications of the Intuity TM heart valve: A rapid deployment bioprosthesis. A systematic review of the literature. J Card Surg 2022, 37, 5411–5417. [Google Scholar] [CrossRef] [PubMed]
- Ng AC, Delgado V, van der Kley F, Shanks M, van de Veire NR, Bertini M, et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging 2010, 3, 94–102. [Google Scholar] [CrossRef] [PubMed]
- Tomii D, Okuno T, Lanz J, Stortecky S, Windecker S, Pilgrim T. Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2023, 101, 199–208. [Google Scholar] [CrossRef] [PubMed]
- Arribas-Leal JM, Rivera-Caravaca JM, Aranda-Domene R, Moreno-Moreno JA, Espinosa-Garcia D, Jimenez-Aceituna A, et al. Mid-term outcomes of rapid deployment aortic prostheses in patients with small aortic annulus. Interactive CardioVascular and Thoracic Surgery 2021, 33, 695–701. [Google Scholar] [CrossRef]
- Jahren SE, Winkler BM, Heinisch PP, Wirz J, Carrel T, Obrist D. Aortic root stiffness affects the kinematics of bioprosthetic aortic valves. Interact Cardiovasc Thorac Surg 2017, 24, 173–180. [Google Scholar]

| Variable | TotalCount | N | N* | Mean | SD | Minimum | Maximum | Confidence Interval 95% |
|---|---|---|---|---|---|---|---|---|
| EuroscoreII | 19 | 19 | 0 | 2.197 | 0.771 | 0.930 | 4.600 | 1.8253- 2.5684 |
| STS SCORE (risk for mortality) | 19 | 19 | 0 | 1.660 | 0.722 | 0.760 | 3.460 | 1.3125 – 2.0083 |
| Age | 19 | 19 | 0 | 76.26 | 6.51 | 64.00 | 85.00 | 73.124 -79.403 |
| Thrombocytes preoperative | 19 | 19 | 0 | 261.4 | 66.2 | 132.0 | 379.0 | 229.45 – 293.29 |
| Thrombocytes postoperative | 19 | 19 | 0 | 178.6 | 45.8 | 83.0 | 257.0 | 156.55 – 200.71 |
| LDH preoperative | 19 | 19 | 0 | 254.8 | 129.3 | 136.0 | 680.0 | 192.53 – 317.15 |
| LDH postoperative | 19 | 19 | 0 | 373.0 | 146.7 | 216.0 | 793.0 | 302.28 – 443.72 |
| HLM time in minutes | 19 | 19 | 0 | 157.5 | 50.4 | 88.0 | 300.0 | 133.25 – 181.80 |
| Cross Clamp Time in minutes | 19 | 19 | 0 | 106.53 | 29.90 | 60.00 | 169.00 | 92.11 – 120.94 |
| Length of stay in days | 19 | 17 | 4 | 13.87 | 9.63 | 0.00 | 41.00 | 8.535 – 19.198 |
| ICU Stay in days | 19 | 17 | 3 | 8.75 | 8.96 | 1.00 | 30.00 | 3.9780 – 13.5220 |
| Hight (cm) | 19 | 19 | 0 | 169.11 | 9.09 | 152.00 | 184.00 | 164.72 – 173.49 |
| Weight (Kg) | 19 | 19 | 0 | 79.74 | 11.56 | 60.00 | 103.00 | 74.167 – 85.307 |
| BSA | 19 | 19 | 0 | 1.9219 | 0.1470 | 1.6000 | 2.1300 | 1.8436 – 2.002 |
| BSA body surface area, ICU: intensive care unit, LDH: Lactate dehydrogenase | ||||||||
| Cohort (n = 19) | Number (n) | Percent (%) |
|---|---|---|
| day mortality | 2 | 10.5 |
| In-hospital mortality | 2 | 10.5 |
| KD | 1 | 5.2 |
| COPD | 2 | 10.5 |
| IDDM | 5 | 26.3 |
| HLP | 4 | 21 |
| PAD | 1 | 5.2 |
| Prior AF | 5 | 26.3 |
| Prior stroke | 1 | 5.2 |
| AV block with PM implant | 1 | 5.2 |
| Delirium | 5 | 26.3 |
| Ischemic stroke | 0 | 0 |
| AF | 2 | 10.5 |
| Mild PVL | 2 | 10.5 |
| Moderate PVL | 1 | 5.2 |
| Severe PVL | 0 | 0 |
| AF: atrial fibrillation; AV: atrioventricular; AVR: aortic valve replacement; COPD: chronic obstructive pulmonary disease; CPB: cardiopulmonary bypass; HLP: hyperlipoproteinaemia; IDDM: insulin-dependent diabetes mellitus; KD: kidney disease; PAD: peripheral artery disease; PM: Pacemaker; PVL: paravalvular leak; SD: standard deviation. | ||
| Variable | Total | N | N* | Mean | StDev | Minimum | Maximum | Confidence Interval 95% |
|---|---|---|---|---|---|---|---|---|
| MPG (mmhg) | 19 | 15 | 4 | 10.552 | 3.581 | 5.000 | 18.000 | 8.569 – 12.535 |
| PPG (mmHg) | 19 | 15 | 4 | 19.42 | 6.08 | 10.00 | 32.00 | 16.058 – 22.792 |
| Velocity Ratio | 19 | 15 | 4 | 0.4813 | 0.0892 | 0.3700 | 0.7000 | 0.43194 – 0.53073 |
| AVAI=EOAI (VTI) cm²/ml2 | 19 | 15 | 4 | 0.8000 | 0.1885 | 0.6000 | 1.3000 | 0.69560 – 0.90440 |
| ET ms | 19 | 15 | 4 | 250.67 | 17.78 | 215.00 | 283.00 | 240.82 – 260.51 |
| AT ms | 19 | 15 | 4 | 75.73 | 7.15 | 58.00 | 88.00 | 71.776 – 79.691 |
| AT: acceleration time; DVI: Doppler velocity indices; EOAI: effective orifice area index; ET: ejection time; MPG: mean pressure gradient; PPG: peak pressure gradient. | ||||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).